Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq

Abstract Neurofibromatosis type 1 (NF1) is caused by loss-of-function variants in the NF1 gene. Approximately 10% of these variants affect RNA splicing and are either missed by conventional DNA diagnostics or are misinterpreted by in silico splicing predictions. Therefore, a targeted RNAseq-based ap...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: R. Koster, R. D. Brandão, D. Tserpelis, C. E. P. van Roozendaal, C. N. van Oosterhoud, K. B. M. Claes, A. D. C. Paulussen, M. Sinnema, M. Vreeburg, V. van der Schoot, C. T. R. M. Stumpel, M. P. G. Broen, L. Spruijt, M. C. J. Jongmans, S. A. J. Lesnik Oberstein, A. S. Plomp, M. Misra-Isrie, F. A. Duijkers, M. J. Louwers, R. Szklarczyk, K. W. J. Derks, H. G. Brunner, A. van den Wijngaard, M. van Geel, M. J. Blok
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Acceso en línea:https://doaj.org/article/982c0d93ba4e444ea8df66af21437691
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:982c0d93ba4e444ea8df66af21437691
record_format dspace
spelling oai:doaj.org-article:982c0d93ba4e444ea8df66af214376912021-11-21T12:42:52ZPathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq10.1038/s41525-021-00258-w2056-7944https://doaj.org/article/982c0d93ba4e444ea8df66af214376912021-11-01T00:00:00Zhttps://doi.org/10.1038/s41525-021-00258-whttps://doaj.org/toc/2056-7944Abstract Neurofibromatosis type 1 (NF1) is caused by loss-of-function variants in the NF1 gene. Approximately 10% of these variants affect RNA splicing and are either missed by conventional DNA diagnostics or are misinterpreted by in silico splicing predictions. Therefore, a targeted RNAseq-based approach was designed to detect pathogenic RNA splicing and associated pathogenic DNA variants. For this method RNA was extracted from lymphocytes, followed by targeted RNAseq. Next, an in-house developed tool (QURNAs) was used to calculate the enrichment score (ERS) for each splicing event. This method was thoroughly tested using two different patient cohorts with known pathogenic splice-variants in NF1. In both cohorts all 56 normal reference transcript exon splice junctions, 24 previously described and 45 novel non-reference splicing events were detected. Additionally, all expected pathogenic splice-variants were detected. Eleven patients with NF1 symptoms were subsequently tested, three of which have a known NF1 DNA variant with a putative effect on RNA splicing. This effect could be confirmed for all 3. The other eight patients were previously without any molecular confirmation of their NF1-diagnosis. A deep-intronic pathogenic splice variant could now be identified for two of them (25%). These results suggest that targeted RNAseq can be successfully used to detect pathogenic RNA splicing variants in NF1.R. KosterR. D. BrandãoD. TserpelisC. E. P. van RoozendaalC. N. van OosterhoudK. B. M. ClaesA. D. C. PaulussenM. SinnemaM. VreeburgV. van der SchootC. T. R. M. StumpelM. P. G. BroenL. SpruijtM. C. J. JongmansS. A. J. Lesnik ObersteinA. S. PlompM. Misra-IsrieF. A. DuijkersM. J. LouwersR. SzklarczykK. W. J. DerksH. G. BrunnerA. van den WijngaardM. van GeelM. J. BlokNature PortfolioarticleMedicineRGeneticsQH426-470ENnpj Genomic Medicine, Vol 6, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Genetics
QH426-470
spellingShingle Medicine
R
Genetics
QH426-470
R. Koster
R. D. Brandão
D. Tserpelis
C. E. P. van Roozendaal
C. N. van Oosterhoud
K. B. M. Claes
A. D. C. Paulussen
M. Sinnema
M. Vreeburg
V. van der Schoot
C. T. R. M. Stumpel
M. P. G. Broen
L. Spruijt
M. C. J. Jongmans
S. A. J. Lesnik Oberstein
A. S. Plomp
M. Misra-Isrie
F. A. Duijkers
M. J. Louwers
R. Szklarczyk
K. W. J. Derks
H. G. Brunner
A. van den Wijngaard
M. van Geel
M. J. Blok
Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq
description Abstract Neurofibromatosis type 1 (NF1) is caused by loss-of-function variants in the NF1 gene. Approximately 10% of these variants affect RNA splicing and are either missed by conventional DNA diagnostics or are misinterpreted by in silico splicing predictions. Therefore, a targeted RNAseq-based approach was designed to detect pathogenic RNA splicing and associated pathogenic DNA variants. For this method RNA was extracted from lymphocytes, followed by targeted RNAseq. Next, an in-house developed tool (QURNAs) was used to calculate the enrichment score (ERS) for each splicing event. This method was thoroughly tested using two different patient cohorts with known pathogenic splice-variants in NF1. In both cohorts all 56 normal reference transcript exon splice junctions, 24 previously described and 45 novel non-reference splicing events were detected. Additionally, all expected pathogenic splice-variants were detected. Eleven patients with NF1 symptoms were subsequently tested, three of which have a known NF1 DNA variant with a putative effect on RNA splicing. This effect could be confirmed for all 3. The other eight patients were previously without any molecular confirmation of their NF1-diagnosis. A deep-intronic pathogenic splice variant could now be identified for two of them (25%). These results suggest that targeted RNAseq can be successfully used to detect pathogenic RNA splicing variants in NF1.
format article
author R. Koster
R. D. Brandão
D. Tserpelis
C. E. P. van Roozendaal
C. N. van Oosterhoud
K. B. M. Claes
A. D. C. Paulussen
M. Sinnema
M. Vreeburg
V. van der Schoot
C. T. R. M. Stumpel
M. P. G. Broen
L. Spruijt
M. C. J. Jongmans
S. A. J. Lesnik Oberstein
A. S. Plomp
M. Misra-Isrie
F. A. Duijkers
M. J. Louwers
R. Szklarczyk
K. W. J. Derks
H. G. Brunner
A. van den Wijngaard
M. van Geel
M. J. Blok
author_facet R. Koster
R. D. Brandão
D. Tserpelis
C. E. P. van Roozendaal
C. N. van Oosterhoud
K. B. M. Claes
A. D. C. Paulussen
M. Sinnema
M. Vreeburg
V. van der Schoot
C. T. R. M. Stumpel
M. P. G. Broen
L. Spruijt
M. C. J. Jongmans
S. A. J. Lesnik Oberstein
A. S. Plomp
M. Misra-Isrie
F. A. Duijkers
M. J. Louwers
R. Szklarczyk
K. W. J. Derks
H. G. Brunner
A. van den Wijngaard
M. van Geel
M. J. Blok
author_sort R. Koster
title Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq
title_short Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq
title_full Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq
title_fullStr Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq
title_full_unstemmed Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq
title_sort pathogenic neurofibromatosis type 1 (nf1) rna splicing resolved by targeted rnaseq
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/982c0d93ba4e444ea8df66af21437691
work_keys_str_mv AT rkoster pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT rdbrandao pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT dtserpelis pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT cepvanroozendaal pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT cnvanoosterhoud pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT kbmclaes pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT adcpaulussen pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT msinnema pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT mvreeburg pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT vvanderschoot pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT ctrmstumpel pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT mpgbroen pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT lspruijt pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT mcjjongmans pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT sajlesnikoberstein pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT asplomp pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT mmisraisrie pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT faduijkers pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT mjlouwers pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT rszklarczyk pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT kwjderks pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT hgbrunner pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT avandenwijngaard pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT mvangeel pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
AT mjblok pathogenicneurofibromatosistype1nf1rnasplicingresolvedbytargetedrnaseq
_version_ 1718418839988862976